TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

GlaxoSmithKline, Pfizer Form Consumer Healthcare Group With $13 Billion in Sales
STOCKS

GlaxoSmithKline, Pfizer Form Consumer Healthcare Group with $13 Billion in Sales

Walt Disney, Papa John's, AT&T, Cigna, Weight Watchers - 5 Things You Must Know
MARKETS

Dow Ends Up Sharply; Stocks Rally on Easing Trade Tensions

GlaxoSmithKline, Pfizer Form Consumer Healthcare Group With $13 Billion in Sales
STOCKS

GlaxoSmithKline Makes $5.1 Billion Play for Cancer Drug Specialist Tesaro

3 Questions Financial Advisers Should Prepare to Hear from Clients
JIM CRAMER

Worried About the Right Thing?: Cramer's 'Mad Money' Recap

Southwest Airlines Extends Boeing 737 MAX Grounding by a Month, Until March 6
JIM CRAMER

JetBlue, Southwest, Johnson & Johnson: 'Mad Money' Lightning Round

Tesaro Bulls Double Their Money
OPTIONS

Tesaro Bulls Double Their Money

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
JIM CRAMER

Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition
MERGERS AND ACQUISITIONS

More Immunotherapy Buyouts Likely After Kite Sale

Acorda Therapeutics Sinks on Invalidated Patents
STOCKS

Tesaro Stock Jumps on Sanofi, Gilead Takeover Interest

Wall Street's Wednesday Slide Chips Away at May's 'Irrational Exuberance'
OPINION

Market Recon: Worryingly, the Indices Seem to Be Almost Resting at Lofty Levels

Clovis Spikes on Phase 3 Data for Ovarian Cancer Drug- Biotech Movers
STOCKS

Biotech Stock Mailbag: Why Clovis Oncology Is Trading Lower on Rubraca Study Update

Gold Rally Is Just Getting Started
STOCKS

Tesaro Resorts to PR Razzle Dazzle to Make Ovarian Cancer Drug Appear Cheaply Priced

Biotech Premarket Movers: Cempra, Tesaro, Editas
HEALTH

Biotech Premarket Movers: Cempra, Tesaro, Editas

Nektar Addiction-Resistant Opioid Reduces Chronic Pain in Late-Stage Study
STOCKS

Tesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian Cancer

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment
STOCKS

AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Strong Ovarian Cancer Study Results

Incyte Pops on Continued Gilead Takeout Speculation
STOCKS

Incyte Pops on Continued Gilead Takeout Speculation

Invest Like a Venture Capitalist With These 4 Stocks
VIDEO

Invest Like a Venture Capitalist With These 4 Stocks

Twilio Shares Poised for a Short-Covering Rally
STOCKS

Forget the Snapchat IPO--invest like a venture capitalist with these 4 stocks

Clovis Spikes on Phase 3 Data for Ovarian Cancer Drug- Biotech Movers
STOCKS

Clovis, Tesaro soar on AstraZeneca phase three news

First Day of Trump Era, and Brick-and-Mortar Retailers: Best of Kass
INVESTING

Morgan stanley, twitter, tesaro: doug kass' views

Analysts' Actions -- Amazon, CVS, Raytheon, Western Digital and More
STOCKS

Analysts' Actions -- Ford, Intel, Twitter, Viacom and More

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
STOCKS

Biotech Tesaro climbs on takeout reports

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

These 3 biotech stocks are already moving wildly on Thursday

17 Thoughts on Biotech Stocks to Kick Off 2017
STOCKS

17 thoughts on biotech stocks to kick off 2017

Analysts' Actions -- Amazon, CVS, Raytheon, Western Digital and More
STOCKS

Analysts' Actions -- Goldman Sachs, Celanese, SBA Communications and More